EPA-0685 – Guanfacine XR (GXR) for children and adolescents with attention-deficit/hyperactivity disorder (ADHD): phase 3, randomized, double-blind, multicenter, placebo- and active-reference study

✍ Scribed by Hervas, A.; Huss, M.; Johnson, M.; McNicholas, F.; Van Stralen, J.; Sreckovic, S.; Lyne, A.; Bloomfield, R.; Sikirica, V.; Robertson, B.

• Book ID: 125820804
• Publisher: Elsevier Science
• Year: 2014
• Tongue: French
• Weight: 121 KB
• Volume: 29
• Category: Article
• ISSN: 0924-9338
• DOI: 10.1016/S0924-9338(14)78052-6